Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier

被引:104
作者
Li, Mu-xia [1 ]
Li, Min-yao [1 ]
Lei, Jun-xuan [1 ]
Wu, Yu-zhu [1 ]
Li, Ze-hao [1 ]
Chen, Lin-ming [2 ]
Zhou, Chang-lin [3 ]
Su, Ji-yan [4 ]
Huang, Guo-xin [5 ]
Huang, Xiao-qi [1 ]
Zheng, Xue-bao [1 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Huibiao Testing Technol Ctr, Guangzhou 510700, Peoples R China
[3] Dongguan Peoples Hosp, Dongguan 523000, Peoples R China
[4] Southern Med Univ, Affiliated Foshan Matern & Child Healthcare Hosp, Foshan 528000, Guangdong, Peoples R China
[5] Shantou Cent Hosp, Clin Res Ctr, Shantou 515041, Peoples R China
关键词
Huangqin decoction; Ulcerative colitis; Gut microbiota; Amino acid metabolism; mTOR pathway; Intestinal epithelial barrier;
D O I
10.1016/j.phymed.2022.154052
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: The clinical treatment of ulcerative colitis (UC) is limited. A traditional Chinese medicinal formula, Huangqin decoction (HQD), is chronicled in Shang Han Lun and is widely used to ameliorate gastrointestinal disorders, such as UC; however, its mechanism is yet to be clarified. Purpose: The present study aimed to investigate the effect of HQD on 7-day colitis induced by 3% dextran sulfate sodium (DSS) in mice and further explore the inhibitory effect of metabolites on DSS-damaged FHC cells. Methods: The therapeutic efficacy of HQD was evaluated in a well-established DSS-induced colitis mice model. The clinical symptoms were analyzed, and biological samples were collected for microscopic examination, metabolomics, metagenomics, and the evaluation of the epithelial barrier function. The mechanism of metabolites regulated by HQD was evaluated in the DSS-induced FHC cell damage model. The samples were collected to detect the physiological functions of the cells. Results: HQD suppressed the inflammation of DSS-induced colitis in vivo, attenuated DSS-induced clinical manifestations, reversed colon length reduction, and reduced histological injury. After HQD treatment, the DSSinduced gut dysbiosis was modulated, and the gut microbiota achieved a new equilibrium state. In addition, HQD activated the mTOR signaling pathway by upregulating amino acid metabolism. Significant phosphorylation of S6 and 4E-BP1 ameliorated intestinal epithelial barrier dysfunction. Moreover, HQD-regulated metabolites protected the epithelial barrier integrity by inhibiting DSS-induced apoptosis of FHC cells and regulating the proteins affecting apoptosis and cell-cell junction. Conclusions: These findings indicated that the mechanism of HQD was related to regulating the gut microbiota and amino acid metabolism, activating the mTOR signaling pathway, and protecting the intestinal mucosal barrier integrity.
引用
收藏
页数:12
相关论文
共 33 条
[1]   The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome [J].
Bourgneuf, Camille ;
Bailbe, Danielle ;
Lamaziere, Antonin ;
Dupont, Charlotte ;
Moldes, Marthe ;
Farabos, Dominique ;
Roblot, Natacha ;
Gauthier, Camille ;
D'Argent, Emmanuelle Mathieu ;
Cohen-Tannoudji, Joelle ;
Monniaux, Danielle ;
Feve, Bruno ;
Movassat, Jamileh ;
di Clemente, Nathalie ;
Racine, Chrystele .
NATURE COMMUNICATIONS, 2021, 12 (01)
[2]   L-arginine Supplementation Improves Responses to Injury and Inflammation in Dextran Sulfate Sodium Colitis [J].
Coburn, Lori A. ;
Gong, Xue ;
Singh, Kshipra ;
Asim, Mohammad ;
Scull, Brooks P. ;
Allaman, Margaret M. ;
Williams, Christopher S. ;
Rosen, Michael J. ;
Washington, M. Kay ;
Barry, Daniel P. ;
Piazuelo, M. Blanca ;
Casero, Robert A., Jr. ;
Chaturvedi, Rupesh ;
Zhao, Zhongming ;
Wilson, Keith T. .
PLOS ONE, 2012, 7 (03)
[3]   The Intestinal Microbiota Plays a Role in Salmonella-Induced Colitis Independent of Pathogen Colonization [J].
Ferreira, Rosana B. R. ;
Gill, Navkiran ;
Willing, Benjamin P. ;
Antunes, L. Caetano M. ;
Russell, Shannon L. ;
Croxen, Matthew A. ;
Finlay, B. Brett .
PLOS ONE, 2011, 6 (05)
[4]   A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis [J].
Henn, Matthew R. ;
O'Brien, Edward J. ;
Diao, Liyang ;
Feagan, Brian G. ;
Sandborn, William J. ;
Huttenhower, Curtis ;
Wortman, Jennifer R. ;
McGovern, Barbara H. ;
Wang-Weigand, Sherry ;
Lichter, David, I ;
Chafee, Meghan ;
Ford, Christopher B. ;
Bernardo, Patricia ;
Zhao, Peng ;
Simmons, Sheri ;
Tomlinson, Amelia D. ;
Cook, David N. ;
Pomerantz, Roger J. ;
Misra, Bharat K. ;
Aunins, John G. ;
Trucksis, Michele .
GASTROENTEROLOGY, 2021, 160 (01) :115-+
[5]   Blood Pressure Abnormalities Associated with Gut Microbiota-Derived Short Chain Fatty Acids in Children with Congenital Anomalies of the Kidney and Urinary Tract [J].
Hsu, Chien-Ning ;
Lu, Pei-Chen ;
Hou, Chih-Yao ;
Tain, You-Lin .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
[6]   PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels [J].
Huang Jiayu ;
Liu Lin ;
Chen Chunyan ;
Gao Ying .
BMC ENDOCRINE DISORDERS, 2020, 20 (01)
[7]   Differential regulation of mTORC1 by leucine and glutamine [J].
Jewell, Jenna L. ;
Kim, Young Chul ;
Russell, Ryan C. ;
Yu, Fa-Xing ;
Park, Hyun Woo ;
Plouffe, Steven W. ;
Tagliabracci, Vincent S. ;
Guan, Kun-Liang .
SCIENCE, 2015, 347 (6218) :194-198
[8]   The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead [J].
Kostic, Aleksandar D. ;
Xavier, Ramnik J. ;
Gevers, Dirk .
GASTROENTEROLOGY, 2014, 146 (06) :1489-1499
[9]   New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD [J].
Larabi, Anais ;
Barnich, Nicolas ;
Hang Thi Thu Nguyen .
AUTOPHAGY, 2020, 16 (01) :38-51
[10]   Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways [J].
Li, Min-yao ;
Luo, Hui-juan ;
Wu, Xue ;
Liu, Yu-hong ;
Gan, Yu-xuan ;
Xu, Nan ;
Zhang, Yao-min ;
Zhang, Shu-hua ;
Zhou, Chang-lin ;
Su, Zi-ren ;
Huang, Xiao-qi ;
Zheng, Xue-bao .
FRONTIERS IN PHARMACOLOGY, 2020, 10